Comerica Bank
MRNA icon

Comerica Bank’s Moderna MRNA Stock Holding History

Comerica Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.02M Sell
34,560
-2,231
-6% -$60.6K ﹤0.01% 1502
2025
Q3 		$950K Sell
36,791
-3
-0% -$84 ﹤0.01% 1577
2025
Q2 		$1.02M Sell
36,794
-28,637
-44% -$754K ﹤0.01% 1523
2025
Q1 		$1.85M Buy
65,431
+29,020
+80% +$1.03M 0.01% 1162
2024
Q4 		$1.51M Sell
36,411
-943
-3% -$45.1K 0.01% 1302
2024
Q3 		$2.5M Sell
37,354
-2,363
-6% -$217K 0.01% 1041
2024
Q2 		$4.72M Sell
39,717
-308
-0.8% -$39K 0.02% 709
2024
Q1 		$4.26M Sell
40,025
-6,717
-14% -$677K 0.02% 806
2023
Q4 		$4.65M Sell
46,742
-577
-1% -$48.5K 0.02% 722
2023
Q3 		$4.89M Buy
47,319
+34,969
+283% +$3.9M 0.03% 633
2023
Q2 		$29 Buy
+12,350
New +$1.65M ﹤0.01% 245
2022
Q4 		$8.45M Sell
44,287
-3,063
-6% -$501K 0.07% 333
2022
Q3 		$6.3M Sell
47,350
-2,233
-5% -$339K 0.05% 401
2022
Q2 		$8.29M Buy
49,583
+658
+1% +$94.1K 0.07% 314
2022
Q1 		$7.34M Buy
48,925
+1,242
+3% +$209K 0.05% 402
2021
Q4 		$7.27M Buy
47,683
+2,970
+7% +$868K 0.05% 388
2021
Q3 		$14.6M Buy
44,713
+29,577
+195% +$10.9M 0.09% 216
2021
Q2 		$5.68M Buy
15,136
+6,260
+71% +$1.12M 0.03% 642
2021
Q1 		$1.54M Sell
8,876
-1,027
-10% -$149K 0.01% 1519
2020
Q4 		$1.3M Sell
9,903
-779
-7% -$78.8K 0.01% 1564
2020
Q3 		$753K Buy
10,682
+528
+5% +$36.8K 0.01% 1724
2020
Q2 		$845K Buy
10,154
+2,102
+26% +$115K 0.01% 1616
2020
Q1 		$407K Buy
+8,052
New +$185K ﹤0.01% 1826

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Comerica Bank's MRNA Position: Q4 2025 in Review

Comerica Bank reduced its Moderna (MRNA) stake by 6.1% in Q4 2025, selling an estimated $60.6K and leaving 34,560 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Comerica Bank first reported a position in MRNA in Q1 2020 and has held it in 23 quarters since. The position peaked at $14.6M in Q3 2021. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Comerica Bank held 34,560 shares of Moderna worth $1.02M as of Q4 2025.
  • Comerica Bank sold 2,231 Moderna shares in Q4 2025, an estimated $60.6K.
  • Moderna made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1502 holding.
  • Comerica Bank first reported a position in Moderna in Q1 2020 and has held it in 23 quarters since.
  • Comerica Bank's Moderna position peaked at $14.6M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.